India: Doctors Without Borders says pharmaceutical firms "chipping away" at laws that protect access to medicines

Get RSS feed of these results

All components of this story

Company response
27 April 2010

Bayer response to concerns raised by Doctors Without Borders regarding access to medicines in India

Author: Bayer

Read the full post here

Company response
27 April 2010

Novartis response to concerns raised by Doctors Without Borders regarding access to medicines in India

Author: Novartis

Read the full post here

Article
27 April 2010

Will Pharma, Trade Agreements Shut Down the Pharmacy of the Developing World? [India]

Author: Tido von Schoen-Angerer, Executive Director of Access to Essential Medicines Campaign, Doctors Without Borders, Huffington Post [USA]

Pharmaceutical companies are chipping away at India's legal safeguards in the courts...Bayer is attempting to clamp down on and delay the approval process required for generics to be marketed as soon as a patent is licensed, revoked or expires. Novartis, having lost a legal marathon challenging the very constitutionality of the most significant parts of Indian patent law, is now before the Indian Supreme Court to water down the use of these crucial provisions. [also refers to Gilead Sciences]

Read the full post here